Zimbabwe has declined a major American healthcare agreement valued at $367m (£272m) over five years due to Washington's insistence on confidential biological samples.
This rejection became public after a internal memorandum from December was leaked, revealing that President Emmerson Mnangagwa deemed the agreement was "skewed".
An official representative later stated that the US was seeking biological samples for research and commercial gain while refused to share the resulting advantages from any future medical innovations.
"We are forced to start the challenging and unfortunate process of scaling back our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the US had furnished more than $1.9bn as health assistance to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has appealed for continued negotiations to reach a agreement acceptable to both sides so the nation's critical HIV programme can proceed.
Wider Context
This development comes after a comparable case in neighbouring Kenya, where a court blocked a similar deal with the US following concerns were filed about the safety of Kenyans' medical information.
Since returning to office last year, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).
USAID had administered aid for the US government, but Trump argued its spending was "wasteful" and his administration was pursuing direct bilateral agreements to enhance transparency and responsibility.
Based on statements, 16 nations in Africa have to date signed similar agreements, representing more than $18.3bn in committed funds.
Details of the Rejected Agreement
This assistance for Zimbabwe would have supported "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We are confident this partnership could have provided significant advantages for Zimbabwean communities, particularly the 1.2 million men, women and children currently on HIV treatment via US-supported initiatives," the Ambassador added.
However, official spokesman Nick Mangwana maintained the arrangement was "unfair".
"Our nation was requested to provide its biological resources and data for a long time, with no equivalent guarantee of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that could result from that provided information," his statement read.
"In essence, our nation would provide the basic resources for scientific discovery with no certainty that the resulting innovations would be available to our people should a future health crisis arise."
Sovereignty and Global Health
Mangwana further said that the US's withdrawal from the global health body and its pursuit of one-on-one health agreements were disrupting structures previously established through the global health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing system created to manage potential global health emergencies.
"This mechanism is intended to ensure that when a nation contributes its data, the benefits – including medicines and cures – are shared equitably, not commercialised solely by those with the resources to create them."
The government's concerns regarding the US deal "must not be interpreted as opposition to America," he added.
"We encourage further dialogue with our US partners on how subsequent collaboration might be designed in a manner that honours the sovereignty and interests of each country."
Medical Community Reaction
Medical experts said it recognised the official position, but recommended that negotiations should continue since a large portion of the nation's Aids initiatives depended on foreign aid.
"If specific concerns arise, including those relating to data governance or implementation frameworks, these can often be resolved through detailed discussion and negotiated safeguards," it said.
This impasse highlights the continuing tensions between accepting crucial foreign assistance and protecting national sovereignty in an increasingly interconnected world.